Preferred frontline regimen for new CLL patients greater than 70 years

Susan M. O’Brien, MD of University of California Irvine discusses the preferred frontline regimen for new CLL patients greater than 70 years at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.

www.scrippshealth.org/cancer